ArticleBMC cancer2014

A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).

George Pentheroudakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.